Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties

Tikhomirov A. S., Litvinova V. A., Andreeva D. V., Tsvetkov V. B., Dezhenkova L. G., Volodina Y. L., Kaluzhny D. N., Treshalin I. D., Schols D., Ramonova A. A., Moisenovich M. M., Shtil A. A., Shchekotikhin A. E.
European Journal of Medicinal Chemistry
Vol.199, Num.112294
Опубликовано: 2020
Тип ресурса: Статья

DOI:10.1016/j.ejmech.2020.112294

Аннотация:
Heteroarene-fused anthraquinone derivatives represent a class of perspective anticancer drug candidates capable of targeting multiple vital processes including drug resistance. Taking advantage of previously demonstrated potential of amide derivatives of heteroarene-fused anthraquinones, we herein dissected the role of the heterocyclic core in antitumor properties. A new series of naphtho[2,3-f]indole-3- and anthra[2,3-b]thiophene-3-carboxamides was synthesized via coupling the respective acids with cyclic diamines. New compounds demonstrated a submicromolar antiproliferative potency close to doxorubicin (Dox) against five tumor cell lines of various tissue origin. In contrast to Dox, the new compounds were similarly cytotoxic for HCT116 colon carcinoma cells (wild type p53) and their isogenic p53 knockout counterparts. Modification of the heterocyclic core changed the targeting properties: the best-in-series naphtho[2,3-f]indole-3-carboxamide 8 formed more affine complexes with DNA du
Ключевые слова:
Anthraquinone; Antitumor activity; Apoptosis; DNA binding; Indole; Multidrug resistance; Reactive oxygen species; Structure-activity relationship; Thiophene; Topoisomerase 1
2 [3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 2 methyl 1h naphtho[2,3 f]indol 1 yl]acetic acid methanesulfonate; 3 (3 aminopiperidine 1 carbonyl) 4,11 dihydroxyanthra[2,3 b]thiophene 5,10 dione methanesulfonate; 3 (3 aminopyrrolidin 1 carbonyl) 1 benzyl 4,11 dihydroxy 2 methyl 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate; 3 (3 aminopyrrolidin 1 carbonyl) 1 ethyl 4,11 dihydroxy 2 methyl 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate; 3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 1,2 dimethyl 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate; 3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 2 methyl 1 (2 oxopropyl) 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate; 3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 2 methyl 1 propyl 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate; 3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 2 methylnaphtho[2,3 f]indole 5,10 dione methanesulfonate; 3 (3 aminopyrrolidin3 1 carbonyl) 4,11 dihydroxyanthra[2,3 b]thiophene 5,10 dione
Язык текста: Английский
ISSN: 1768-3254
Tikhomirov A. S.
Litvinova V. A.
Andreeva D. V.
Tsvetkov V. B. Vladimir Borisovich 1964-
Dezhenkova L. G.
Volodina Y. L.
Kaluzhny D. N.
Treshalin I. D.
Schols D.
Ramonova A. A.
Moisenovich M. M.
Shtil A. A.
Shchekotikhin A. E.
Тихомиров А. С.
Литвинова В. А.
Андреева Д. В.
Цветков В. Б. Владимир Борисович 1964-
Деженкова Л. Г.
Володина Y. Л.
Калужнy Д. Н.
Трешалин И. Д.
Счолс Д.
Рамонова А. А.
Моисенович М. М.
Штил А. А.
Шчекотихин А. Е.
Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties
Текст визуальный непосредственный
European Journal of Medicinal Chemistry
Elsevier Science Publisher B.V.
Vol.199 Num.112294
2020
Статья
Anthraquinone Antitumor activity Apoptosis DNA binding Indole Multidrug resistance Reactive oxygen species Structure-activity relationship Thiophene Topoisomerase 1
2 [3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 2 methyl 1h naphtho[2,3 f]indol 1 yl]acetic acid methanesulfonate 3 (3 aminopiperidine 1 carbonyl) 4,11 dihydroxyanthra[2,3 b]thiophene 5,10 dione methanesulfonate 3 (3 aminopyrrolidin 1 carbonyl) 1 benzyl 4,11 dihydroxy 2 methyl 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate 3 (3 aminopyrrolidin 1 carbonyl) 1 ethyl 4,11 dihydroxy 2 methyl 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate 3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 1,2 dimethyl 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate 3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 2 methyl 1 (2 oxopropyl) 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate 3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 2 methyl 1 propyl 1h naphtho[2,3 f]indole 5,10 dione methanesulfonate 3 (3 aminopyrrolidin 1 carbonyl) 4,11 dihydroxy 2 methylnaphtho[2,3 f]indole 5,10 dione methanesulfonate 3 (3 aminopyrrolidin3 1 carbonyl) 4,11 dihydroxyanthra[2,3 b]thiophene 5,10 dione
Heteroarene-fused anthraquinone derivatives represent a class of perspective anticancer drug candidates capable of targeting multiple vital processes including drug resistance. Taking advantage of previously demonstrated potential of amide derivatives of heteroarene-fused anthraquinones, we herein dissected the role of the heterocyclic core in antitumor properties. A new series of naphtho[2,3-f]indole-3- and anthra[2,3-b]thiophene-3-carboxamides was synthesized via coupling the respective acids with cyclic diamines. New compounds demonstrated a submicromolar antiproliferative potency close to doxorubicin (Dox) against five tumor cell lines of various tissue origin. In contrast to Dox, the new compounds were similarly cytotoxic for HCT116 colon carcinoma cells (wild type p53) and their isogenic p53 knockout counterparts. Modification of the heterocyclic core changed the targeting properties: the best-in-series naphtho[2,3-f]indole-3-carboxamide 8 formed more affine complexes with DNA du